… enrolling on oncology clinical trials and receiving a COVID-19 vaccine. Clinical trial sponsors,
… operational guidance on COVID-19 vaccination for patients with cancer who are currently …

… Certain study activities were permitted to be performed by local healthcare providers or …
study during these challenging times. We discuss the impact of COVID-19 on cancer clinical trials …

… by the National Cancer Institute … clinical trials exploring vaccines or anti–COVID-19
therapies started recruitment in record times, a process we hope can be applied to cancer trials…

… clinical trials and commercial applications [25]. Since the success of Doxil, Onpattro, and
various other LNPs in clinical trials, a myriad of studies … used for cancer drug delivery. We also …

… COVID-19 yet the poor survival outcome of many cancer … and research staff driving important
change in clinical research … any clinical trial participants diagnosed with COVID-19 at our …

… tested on COVID-19 to see which were listed in clinical trials (… about repurposed drugs and
clinical trials for COVID-19. In the … list of anticancer drug candidates for COVID-19 treatment. …

… the disproportionate burden of COVID-19 diagnoses and deaths … of cancer clinical trials
will likely slow the pace of clinical … of the COVID-19 outbreak with new clinical trial activations. …

… between the pandemic and clinical research and development for an as yet non-COVID-19–associated
condition, cancer, by studying the initiation of oncology clinical trials over time. …

… global disruption to clinical practice. This article will review the impact that the pandemic
has had on oncology clinical trials. It will assess the effect of the COVID-19 situation on the …

… clinical trial activities at two large cancer centers [Dana-Farber Cancer Institute, Boston, MA
(DFCI) and the Tisch Cancer … patient accruals to oncological trials (hereafter called institution-…